Takeda Pharmaceutical Company Limited (FRA:TKD)

Accolade Statistics

Total Valuation

FRA:TKD has a market cap or net worth of EUR 38.51 billion. The enterprise value is 65.94 billion.

Market Cap	38.51B
Enterprise Value	65.94B

Important Dates

The last earnings date was Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	1.56B
Shares Outstanding	n/a
Shares Change (YoY)	+1.18%
Shares Change (QoQ)	+0.42%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.56B

Valuation Ratios

The trailing PE ratio is 47.66.

PE Ratio	47.66
Forward PE	n/a
PS Ratio	1.46
PB Ratio	0.95
P/TBV Ratio	n/a
P/FCF Ratio	7.16
P/OCF Ratio	5.92
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.91, with an EV/FCF ratio of 12.26.

EV / Earnings	81.60
EV / Sales	2.52
EV / EBITDA	8.91
EV / EBIT	20.31
EV / FCF	12.26

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.73.

Current Ratio	1.16
Quick Ratio	0.47
Debt / Equity	0.73
Debt / EBITDA	3.97
Debt / FCF	5.53
Interest Coverage	4.20

Financial Efficiency

Return on equity (ROE) is 1.87% and return on invested capital (ROIC) is 2.71%.

Return on Equity (ROE)	1.87%
Return on Assets (ROA)	2.31%
Return on Invested Capital (ROIC)	2.71%
Return on Capital Employed (ROCE)	4.73%
Revenue Per Employee	557,199
Profits Per Employee	17,029
Employee Count	47,455
Asset Turnover	0.30
Inventory Turnover	1.25

Taxes

In the past 12 months, FRA:TKD has paid 306.83 million in taxes.

Income Tax	306.83M
Effective Tax Rate	27.49%

Stock Price Statistics

The stock price has decreased by -0.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-0.24%
50-Day Moving Average	25.49
200-Day Moving Average	25.80
Relative Strength Index (RSI)	40.69
Average Volume (20 Days)	404

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:TKD had revenue of EUR 26.44 billion and earned 808.10 million in profits. Earnings per share was 0.50.

Revenue	26.44B
Gross Profit	17.18B
Operating Income	3.30B
Pretax Income	1.12B
Net Income	808.10M
EBITDA	7.19B
EBIT	3.30B
Earnings Per Share (EPS)	0.50

Balance Sheet

The company has 2.07 billion in cash and 29.75 billion in debt, giving a net cash position of -27.69 billion.

Cash & Cash Equivalents	2.07B
Total Debt	29.75B
Net Cash	-27.69B
Net Cash Per Share	n/a
Equity (Book Value)	40.52B
Book Value Per Share	25.94
Working Capital	2.03B

Cash Flow

In the last 12 months, operating cash flow was 6.51 billion and capital expenditures -1.13 billion, giving a free cash flow of 5.38 billion.

Operating Cash Flow	6.51B
Capital Expenditures	-1.13B
Free Cash Flow	5.38B
FCF Per Share	n/a

Margins

Gross margin is 64.98%, with operating and profit margins of 12.48% and 3.06%.

Gross Margin	64.98%
Operating Margin	12.48%
Pretax Margin	4.22%
Profit Margin	3.06%
EBITDA Margin	27.21%
EBIT Margin	12.48%
FCF Margin	20.33%

Dividends & Yields

This stock pays an annual dividend of 1.21, which amounts to a dividend yield of 4.80%.

Dividend Per Share	1.21
Dividend Yield	4.80%
Dividend Growth (YoY)	3.00%
Years of Dividend Growth	n/a
Payout Ratio	226.17%
Buyback Yield	-1.18%
Shareholder Yield	3.62%
Earnings Yield	2.10%
FCF Yield	13.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:TKD has an Altman Z-Score of 1.16 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.16
Piotroski F-Score	6